Global Surgical Instruments Market Size and Forecast To 2027

1 INTRODUCTION OF GLOBAL SURGICAL INSTRUMENTS MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL SURGICAL INSTRUMENTS MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL SURGICAL INSTRUMENTS MARKET, BY PRODUCT
5.1 Overview
5.2 Surgical Sutures and Staples
5.2.1 Surgical Sutures
5.2.2 Surgical Staples
5.3 Handheld Surgical equipment
5.3.1 Forceps and Spatulas
5.3.2 Retractors
5.3.3 Auxiliary Instruments
5.3.4 Dilators
5.3.5 Graspers
5.3.6 Cutter Instruments
5.3.7 Others
5.4 Electrosurgical Devices
6 GLOBAL SURGICAL INSTRUMENTS MARKET, BY CATEGORY
6.1 Overview
6.2 Reusable Surgical Equipment
6.3 Disposable Surgical Equipment

7 GLOBAL SURGICAL INSTRUMENTS MARKET, BY APPLICATION
7.1 Overview
7.2 Neurosurgery
7.3 Plastic and Reconstructive Surgeries
7.4 Wound Closure
7.5 Urology
7.6 Cardiovascular Surgery
7.7 Orthopedic Surgery
7.8 Laparoscopy
7.9 Others

8 GLOBAL SURGICAL INSTRUMENTS MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World

9 GLOBAL SURGICAL INSTRUMENTS MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 B. Braun Melsungen AG
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Boston Scientific Corporation
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Conmed Corporation
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 KLS Martin Group
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Medtronic Plc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Novartis International AG
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 Smith & Nephew Plc.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Entrhal Medical GmbH
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Fuhrmann GmbH
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Johnson & Johnson
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

10.11 Stryker Corporation
10.11.1 Overview
10.11.2 Financial Performance
10.11.3 Product Outlook
10.11.4 Key Developments

10.12 Zimmer Biomet
10.12.1 Overview
10.12.2 Financial Performance
10.12.3 Product Outlook
10.12.4 Key Developments
11 Appendix
11.1 Related Reports